TITLE

Cost effectiveness of heart drugs varies widely, study says

AUTHOR(S)
Dobson, Roger
PUB. DATE
May 2007
SOURCE
BMJ: British Medical Journal (International Edition);5/5/2007, Vol. 334 Issue 7600, p922
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article reports on a study that shows the cost effectiveness for treatments for coronary heart disease varies more than 100-fold. It found that the cost for each life year gained through the administration of aspirin and β blockers for secondary prevention after a heart attack worked out at less than £1,000 where the cost of statins used for primary prevention of heart attack in men aged 35-44 was about £ 70,000. The report also looked at the cost effectiveness of other treatments such as angiotensin converting enzyme (ACE) inhibitors, cardiac rehabilitation, coronary artery bypass graft surgery and angioplasty.
ACCESSION #
24999954

 

Related Articles

  • Improve adherence to guideline medications in older patients who have undergone coronary bypass surgery.  // Drugs & Therapy Perspectives;Oct2012, Vol. 28 Issue 10, p24 

    The article focuses on the adherence to guidelines related to drugs in coronary bypass grafting (CABG) surgery old patients. It discusses changes in old patients and issues which should be addressed in such patients. It highlights that hospitals can implement a care plan and help patients to...

  • Angioplasty/stenting takes another hit. HOLLINGSWORTH, CATHERINE // Cardiovascular Devices & Drugs;Sep2008, Vol. 14 Issue 9, p13 

    The article discusses research on the cost effectiveness of angioplasty and stenting. It references a study conducted by William Weintraub of Christiana Care Health System and colleagues, published in an issue of the "New England Journal of Medicine." The researchers examined 2,287 patients with...

  • Optimal Medical Therapy for Coronary Artery Disease in 2011--Perspectives from the STICH Trial. Whayne, Thomas F.; Saha, Sibu P.; Quevedo, Karla; Mukherjee, Debabrata // Cardiovascular & Hematological Agents in Medicinal Chemistry;2011, Vol. 9 Issue 4, p269 

    Medical, percutaneous interventional, and surgical treatments for the management of coronary heart disease have progressed markedly during the past decade. There is evidence to suggest that for patients with stable coronary heart disease optimal medical therapy is equal in effectiveness for...

  • Preoperative Cardiac Evaluation of the Vascular Surgery Patient—An Anesthesia Perspective. Omar, Hesham R.; Mangar, Devanand; Camporesi, Enrico M. // Vascular & Endovascular Surgery;Jun2012, Vol. 46 Issue 3, p201 

    The morbidity and mortality associated with vascular surgery procedures are largely the results of cardiac events. National guidelines have been regularly proposed and updated by the American College of Cardiology (ACC)/American Heart Association (AHA) to ensure optimal perioperative management...

  • Which drugs should post-MI patients routinely receive? Lin, Victor; Holman, John R.; Barbara Jamieson // Journal of Family Practice;Sep2010, Vol. 59 Issue 9, p527 

    The article focuses on the drugs that should be given to patients post-myocardial infraction (IM). It discusses the benefits of aspirin in reducing mortality and reinfraction rates in MI patients and mentions that early invasive therapy with statin is beneficial in reducing the levels of...

  • Drug interactions of antihypertensive agents. Opie, L. H. // South African Family Practice;Apr/May2012, Vol. 54 Issue 2, pS23 

    The article discusses the drug interactions of various classes of antihypertensive drugs. It notes the vulnerability of metoprolol, carvedilol and propranol to hepatic interactions. Both statins and beta blockers interact with verapamil. Information on the mechanism of action of nifedipine. An...

  • Get the Most out of Your Meds. Harrar, Sarí; Verkler, Erin // Prevention;Nov2003, Vol. 55 Issue 11, p173 

    Presents a chart of different medicines and the time of day in which each medicine is most efficient, including beta-blockers, ACE inhibitors and cholesterol-lowering statins.

  • CABG or angioplasty? In these two trials it's close, but CABG gets the nod.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p45 

    Presents an abstract of the article `A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary Disease,' by C.W. Hamm, J. Reimers, et al from the periodical `The New England Journal of Medicine,' dated October 20, 1994.

  • Myocardial revascularization in 1997: Angioplasty versus... Faxon, David P. // American Family Physician;10/1/1997, Vol. 56 Issue 5, p1409 

    Focuses on angioplasty and coronary artery bypass graft surgery for the treatment of patients with coronary artery disease and severe ischemia. Information on the first coronary artery bypass graft surgery; Information on the Randomized Intervention Treatment of Angina (RITA) Trial, the first...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics